To date, there is no consensus regarding PD-L1 expression and prognosis of patients with GC, as some studies have suggested improved outcomes, while others have not (Böger et al., 2016; Eto et al., 2016; Muro et al., 2016; Schlößer et al., 2016). This evidence concerns the gene CD274 and gastric cancer.